Telaprevir in HIV/HCV-coinfected patients: a new standard with a short half-life

ISSN： 1746-0794

Source： Future Virology, Vol.8, Iss.8, 2013-08, pp. : 735-743

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Lornoxicam: A Short Half-life Oxicam

By Skjodt N.M.

Clinical Pharmacokinetics, Vol. 34, Iss. 6, 1998-06 ,pp. : 421-428

Adis International

Access to resources Recommend Favorite

Adefovir monotherapy not for HBV + HIV co-infected patients

Reactions Weekly, Vol. 1, Iss. 1066, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Non-Invasive Markers of Liver Fibrosis in HCV Mono-Infected and in HIV/HCV Co-Infected Subjects

Medicinal Chemistry, Vol. 4, Iss. 6, 2008-11 ,pp. : 513-519

Bentham Science Publishers

Access to resources Recommend Favorite

HCV Treatment Decision-Making Substance Use Experiences and Hepatitis C Treatment Decision-Making Among HIV/HCV Coinfected Adults

By Ogawa Lisa M. Fink Bova Carol

Substance Use & Misuse, Vol. 44, Iss. 7, 2009-06 ,pp. : 915-933

Informa Healthcare

Access to resources Recommend Favorite

Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a-/- Model

Current Pharmaceutical Design, Vol. 21, Iss. 39, 2015-12 ,pp. : 5736-5748

Bentham Science Publishers

Access to resources Recommend Favorite